Marizyme, Inc.

MRZM · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$69,539-$38,166-$10,998-$5,845
Dep. & Amort.$841$841$44$591
Deferred Tax$0$0$1,032$254
Stock-Based Comp.$527$1,906$898$1,330
Change in WC$2,821-$2,476$1,724$209
Other Non-Cash$60,665$27,043$1,513$238
Operating Cash Flow-$4,685-$10,852-$5,787-$3,224
Investing Activities
PP&E Inv.$0$0$0-$149
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0-$149
Financing Activities
Debt Repay.$1,217$787$264$0
Stock Issued$2,840$6,501$6,693$6,275
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$265$0$0$0
Financing Cash Flow$4,322$7,291$6,957$6,275
Forex Effect$0$0$0$0
Net Chg. in Cash-$362-$3,561$1,170$2,903
Supplemental Information
Beg. Cash$511$4,072$2,903$0
End Cash$148$511$4,072$2,903
Free Cash Flow-$4,685-$10,852-$5,787-$3,372